Ophthalmic Viscoelastic Devices Market: By Type and Dispersive Ophthalmic Viscoelastic Devices ), By Application, By End User, and Region Forecast 2019-2030
Ophthalmic Viscoelastic Devices (OVDs) Market Size was valued at US$ 2,941 million in 2023 and is expected to grow US$ 4,227 million by 2030 growing at a significant 4.14% from 2024-2030. This market in a variety of eye surgeries, including cataract surgery, glaucoma surgery, and others. These devices help to protect the fragile ocular tissues by producing pressure in the anterior chamber, compartmentalising inside the eye, and allowing patients to have a speedier and safer surgery with a faster recovery. Depending on the situation, ophthalmologists use a variety of ophthalmic instruments.
As a result, ophthalmic viscoelastic devices serve a critical role in the treatment of various eye diseases during surgery all over the world. Ophthalmic viscoelastic devices (OVDs) are the medical devices that are used in the cataract surgery in order to create and maintain the space in the anterior chamber of the eye during phacoemulsification and implantation of an intraocular lens (IOL). There are various types of the ophthalmic viscoelastic devices such as dispersive ophthalmic viscoelastic device and cohesive ophthalmic viscoelastic device.
Most of the ophthalmic viscoelastic devices (OVDs) contain sodium hyaluronate (NaHA) or hydroxypropyl methylcellulose (HPMC). The surge in government initiatives aimed at establishing rules to control the global increase in vision impairment is pressuring major manufacturers to release new ophthalmic products. Other factors that contribute to the growth of the market include an increase in the prevalence of cataracts and glaucoma, an increase in the number of eye procedures performed, and an increase in the geriatric population. The market is also expected to rise due to an increase in the adoption of viscoelastic devices around the world.
Study Period
2024-2030Base Year
2023CAGR
4.14%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
Increase in the prevalence of eye diseases and rise in the number of cataract and glaucoma surgeries are driving the growth of ophthalmic viscoelastic devices (OVDs) market. The favorable reimbursement policies for surgeries using ophthalmic viscoelastic devices (OVDs) and strategic approach of the manufacturers help them sustain the growth and expansion in the market. The collaborations, mergers and acquisitions among vendors are helping to drive the R&D activities which are expected to create the market growth. However, the availability of alternate therapies, poor healthcare infrastructure, and the lack of awareness among the healthcare fraternity may hinder the growth of the market over the forecast period.
Geographically, global ophthalmic viscoelastic devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America market growth driven by increase in the prevalence of eye diseases. The growing geriatric population and higher adoption of the newer technology expected to drive the market growth in the region. Falling in the second place is the European region. The growing awareness about the advanced treatments among the patient population and large disposable income is emerging markets in the region driving the market revenue growth. The Asia Pacific region is expected to be growing faster over the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 2,941 million |
|
Market Size in 2030 |
US$ 4,227 million |
|
Market CAGR |
4.14% |
|
By Type |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
Ophthalmic viscoelastic devices market size was valued at US$ 2,941 Mn in 2023 and is set to reach US$ 4,227 Mn in 2030 at a CAGR of 6.9% from 2024-2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
Johnson & Johnson, Alcon Laboratories Inc., Bausch & Lomb, Carl Zeiss AG, Rayner Company, Bohus BioTech AB, Lifecore Biomedical LLC
| 1.Executive Summary |
| 2.Global Ophthalmic Viscoelastic Devices (OVDs) Market Introduction |
| 2.1.Global Ophthalmic Viscoelastic Devices (OVDs) Market - Taxonomy |
| 2.2.Global Ophthalmic Viscoelastic Devices (OVDs) Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Route of Administration |
| 2.2.5.Region |
| 3.Global Ophthalmic Viscoelastic Devices (OVDs) Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Ophthalmic Viscoelastic Devices (OVDs) Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Ophthalmic Viscoelastic Devices (OVDs) Market By Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD) |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 6.Global Ophthalmic Viscoelastic Devices (OVDs) Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Vitreoretinal Surgery |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Glaucoma Surgery |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Cataract Surgery |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Corneal Transplantation |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Ophthalmic Viscoelastic Devices (OVDs) Market By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ophthalmology Clinics |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Ophthalmic Viscoelastic Devices (OVDs) Market By Route of Administration, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. Injection |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Nasal Spray |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 9.Global Ophthalmic Viscoelastic Devices (OVDs) Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Ophthalmic Viscoelastic Devices (OVDs) Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD) |
| 10.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Vitreoretinal Surgery |
| 10.2.2.Glaucoma Surgery |
| 10.2.3.Cataract Surgery |
| 10.2.4.Corneal Transplantation |
| 10.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Ophthalmology Clinics |
| 10.3.3.Others |
| 10.4. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Injection |
| 10.4.2.Nasal Spray |
| 10.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Ophthalmic Viscoelastic Devices (OVDs) Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD) |
| 11.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Vitreoretinal Surgery |
| 11.2.2.Glaucoma Surgery |
| 11.2.3.Cataract Surgery |
| 11.2.4.Corneal Transplantation |
| 11.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Ophthalmology Clinics |
| 11.3.3.Others |
| 11.4. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Injection |
| 11.4.2.Nasal Spray |
| 11.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Ophthalmic Viscoelastic Devices (OVDs) Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD) |
| 12.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Vitreoretinal Surgery |
| 12.2.2.Glaucoma Surgery |
| 12.2.3.Cataract Surgery |
| 12.2.4.Corneal Transplantation |
| 12.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Ophthalmology Clinics |
| 12.3.3.Others |
| 12.4. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Injection |
| 12.4.2.Nasal Spray |
| 12.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Ophthalmic Viscoelastic Devices (OVDs) Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD) |
| 13.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Vitreoretinal Surgery |
| 13.2.2.Glaucoma Surgery |
| 13.2.3.Cataract Surgery |
| 13.2.4.Corneal Transplantation |
| 13.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Ophthalmology Clinics |
| 13.3.3.Others |
| 13.4. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Injection |
| 13.4.2.Nasal Spray |
| 13.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Ophthalmic Viscoelastic Devices (OVDs) Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD) |
| 14.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Vitreoretinal Surgery |
| 14.2.2.Glaucoma Surgery |
| 14.2.3.Cataract Surgery |
| 14.2.4.Corneal Transplantation |
| 14.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Hospitals |
| 14.3.2.Ophthalmology Clinics |
| 14.3.3.Others |
| 14.4. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Injection |
| 14.4.2.Nasal Spray |
| 14.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.ohnson & Johnson ((U.S) |
| 15.2.2.Alcon Laboratories Inc. (Switzerland) |
| 15.2.3.Bausch & Lomb (U.S) |
| 15.2.4.Carl Zeiss AG (Germany) |
| 15.2.5.Rayner Company (UK) |
| 15.2.6.Bohus BioTech AB (Sweden) |
| 15.2.7.Lifecore Biomedical LLC (U.S) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
